FDA Approves Ruxolitinib (Opzelura) for Vitiligo
This new topical JAK inhibitor cream is the first medication that can restore skin pigment in people with the autoimmune disease vitiligo.
Source: everydayhealth.com
Stay updated with breaking news from Means Better Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This new topical JAK inhibitor cream is the first medication that can restore skin pigment in people with the autoimmune disease vitiligo.